Company Filing History:
Years Active: 2019
Title: Innovations in Cancer Screening by Hungcheng Lai
Introduction
Hungcheng Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in cancer screening methods. His innovative approach aims to enhance the accuracy and efficiency of cancer detection.
Latest Patents
Hungcheng Lai holds a patent for a method for screening cancer. This invention involves several steps: first, providing a specimen to be detected; second, detecting the methylation status of CpG sequences of at least one target gene, which includes genes such as ADRA1D, AJAP1, HS3ST2, MAGI2, POU4F2, POU4F3, PTGDR, SOX17, and SYT9 in the genomic DNA of the specimen; and third, determining the presence of cancer or precancerous lesions based on the methylation status of at least one target gene. This method represents a significant advancement in cancer diagnostics.
Career Highlights
Hungcheng Lai is affiliated with the National Defense Medical Center, where he applies his expertise in medical research and innovation. His work focuses on developing methods that can lead to earlier and more reliable cancer detection, ultimately improving patient outcomes.
Conclusion
Hungcheng Lai's contributions to cancer screening technology exemplify the impact of innovative thinking in the medical field. His patent for a method of screening cancer showcases his commitment to advancing healthcare solutions.